Kuan Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kuan Fan has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Hao Deng
Health Management Center, the Third Xiangya Hospital, Central South University, Changsha, China
2 shared publications - Chengyuan Song
Department of Neurology, The Qilu Hospital, Shandong University, Jinan, China
1 shared publication Haixia Zhu
Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, People's Republic of China
1 shared publicationHongbo Xu
Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, Hunan, 410013, People's Republic of China
1 shared publication- Jie Wen
Department of Neurosurgery Xiangya Hospital Central South University Changsha China
1 shared publication - Lamei Yuan
Affiliations Health Management Center, the Third Xiangya Hospital, Central South University, Changsha, China, Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, China, Disease Genome Research Center, Central South University, Changsha, China, Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 23 December 2019
- Published by Wiley in Parkinson's Disease
- Vol. 2019, 1-6
Novel Compound Heterozygous PRKN Variants in a Han-Chinese Family with Early-Onset Parkinson’s Disease
Genetic factors are thought to play an important role in the pathogenesis of Parkinson’s disease (PD), particularly early-onset PD. The PRKN gene is the primary disease-causing gene for early-onset PD. The details of its functions remain unclear. This study identified novel compound heterozygous variants (p.T240K and p.L272R) of the PRKN gene in a Han-Chinese family with early-onset PD. This finding is helpful in the genetic diagnosis of PD and also the functional research of the PRKN gene.
- 23 December 2019
- Published by Wiley in Parkinson's Disease
- Vol. 2019, 1-6
Open AccessNovel Compound Heterozygous PRKN Variants in a Han-Chinese Family with Early-Onset Parkinson’s Disease
Genetic factors are thought to play an important role in the pathogenesis of Parkinson’s disease (PD), particularly early-onset PD. The PRKN gene is the primary disease-causing gene for early-onset PD. The details of its functions remain unclear. This study identified novel compound heterozygous variants (p.T240K and p.L272R) of the PRKN gene in a Han-Chinese family with early-onset PD. This finding is helpful in the genetic diagnosis of PD and also the functional research of the PRKN gene.
- 23 November 2018
- Published by Springer Nature in Journal of Neurology
- Vol. 266 (1) , 232-241
The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis
Familial amyloid polyneuropathies (FAPs) are life-threatening, autosomal dominant diseases resulting, in most instances, from transthyretin gene (TTR) variants. A small number of TTR variants lead to leptomeningeal amyloidosis (LA), which is a rare FAP subtype with late-onset central nervous system (CNS) impairment symptoms. Previous studies suggest that LA’s CNS selectivity was due to complete endoplasmic reticulum-associated degradation of highly destabilized mutants in peripheral tissues. LA’s later age at onset (AAO) was due to lower choroid plexus secretory efficacy. This study reports on a family with LA, including six symptomatic and three presymptomatic members. The LA diagnosis was confirmed by leptomeningeal enhancement on contrast MRI, elevated cerebrospinal fluid protein levels, and positive Congo red staining. The predominant symptoms included headaches, dizziness, vomiting, hallucinations, and cognitive impairments which associated with obstructive hydrocephalus. The TTR p.D38G variant with the lowest secretory efficacy was identified as the genetic cause by whole exome sequencing. The family had a statistically significantly earlier mean AAO of 31.3 ± 7.4 (p = 0.001). These uncommon phenotypes indicate unknown factors influencing the progress of CNS impairment via TTR mutants. Medical imaging examinations suggest the potential early diagnosis value of contrast MRI and the importance of ependyma involvement in LA. LA genetic and clinical data were reviewed and summarized. These findings expand the FAPs’ phenotypic spectrum and are valuable in FAP diagnosis, treatment, and further research.
- 23 November 2018
- Published by Springer Nature in Journal of Neurology
- Vol. 266 (1) , 232-241
The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis
Familial amyloid polyneuropathies (FAPs) are life-threatening, autosomal dominant diseases resulting, in most instances, from transthyretin gene (TTR) variants. A small number of TTR variants lead to leptomeningeal amyloidosis (LA), which is a rare FAP subtype with late-onset central nervous system (CNS) impairment symptoms. Previous studies suggest that LA’s CNS selectivity was due to complete endoplasmic reticulum-associated degradation of highly destabilized mutants in peripheral tissues. LA’s later age at onset (AAO) was due to lower choroid plexus secretory efficacy. This study reports on a family with LA, including six symptomatic and three presymptomatic members. The LA diagnosis was confirmed by leptomeningeal enhancement on contrast MRI, elevated cerebrospinal fluid protein levels, and positive Congo red staining. The predominant symptoms included headaches, dizziness, vomiting, hallucinations, and cognitive impairments which associated with obstructive hydrocephalus. The TTR p.D38G variant with the lowest secretory efficacy was identified as the genetic cause by whole exome sequencing. The family had a statistically significantly earlier mean AAO of 31.3 ± 7.4 (p = 0.001). These uncommon phenotypes indicate unknown factors influencing the progress of CNS impairment via TTR mutants. Medical imaging examinations suggest the potential early diagnosis value of contrast MRI and the importance of ependyma involvement in LA. LA genetic and clinical data were reviewed and summarized. These findings expand the FAPs’ phenotypic spectrum and are valuable in FAP diagnosis, treatment, and further research.